Company Filing History:
2 out of 27 
2 out of 1,332 
1 out of 833,002 Years Active: 1999-2004
Title: Anna Mary Myat: Innovator in Serrate Protein Research
Introduction
Anna Mary Myat is a distinguished inventor based in Oxford, GB. She has made significant contributions to the field of biotechnology, particularly in the study of Serrate proteins. With a total of 3 patents to her name, her work has implications for therapeutic and diagnostic methods.
Latest Patents
Myat's latest patents focus on antibodies to vertebrate Serrate proteins and their fragments. The inventions relate to nucleotide sequences of Serrate genes and the amino acid sequences of their encoded proteins. In particular, her work emphasizes the human Serrate protein and its various domains, including the intracellular domain, extracellular domain, DSL domain, cysteine-rich domain, transmembrane region, and EGF-like repeats. Additionally, her patents provide methods for producing Serrate proteins and their derivatives, as well as therapeutic and diagnostic applications.
Career Highlights
Throughout her career, Anna Mary Myat has worked with notable organizations such as Imperial Cancer Research Technology, Ltd. and Yale University. Her research has been pivotal in advancing our understanding of Serrate proteins and their potential applications in medicine.
Collaborations
Myat has collaborated with esteemed colleagues, including David Ish-Horowicz and Julian Hart Lewis. These partnerships have further enriched her research and contributed to her innovative work in the field.
Conclusion
Anna Mary Myat's contributions to the study of Serrate proteins exemplify her dedication to innovation in biotechnology. Her patents and collaborations highlight her role as a leading inventor in this important area of research.